Find clinical trials for Lymphoma in Indianapolis, IN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Indianapolis, IN, USA:
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Indianapolis, Indiana, United States and 71 other locations
on participants who have one of two types of cancer: follicular lymphoma (FL) or marginal zone lymphoma (MZL) that has come back af...
Phase 3
Indianapolis, Indiana, United States and 124 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Indianapolis, Indiana, United States and 215 other locations
the maximum tolerated dose (MTD) of ruxolitinib when given with fixed dose nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 4 other locations
Single arm phase I/II study of ixazomib and romidepsin in relapsed/refractory PTCL. Each cycle is 28 days. Patients will continue to receive therapy...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 6 other locations
1, open-label, multicenter study of WTX-330 administered as a monotherapy to patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma...
Phase 1
Indianapolis, Indiana, United States and 8 other locations
is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin lymphoma or NHL).This study will be...
Phase 3
Noblesville, Indiana, United States and 136 other locations
Follicular Lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this dise...
Phase 3
Indianapolis, Indiana, United States and 281 other locations
is focused on participants with previously untreated follicular lymphoma. Follicular lymphoma is a type of non-Hodgkin lymphoma...
Phase 3
Noblesville, Indiana, United States and 71 other locations
This is a Phase 1/2, multi-center, open-label study evaluating the safety and efficacy of IMPT-314, a bispecific chimeric antigen receptor (CAR) targ...
Phase 1, Phase 2
Indianapolis, Indiana, United States of America and 14 other locations
Clinical trials
Research sites
Resources
Legal